<DOC>
	<DOCNO>NCT00542139</DOCNO>
	<brief_summary>This study perform assess influence intraarticular injection 2ml Diprospan ( wich contain 4mg Betamethasone sodium phosphate 10mg Betamethasone dipropionate ) osteoarthritic knee patient undergo total knee replacement contralateral knee . The study population include 50 patient bilateral knee osteoarthritis , admit first knee replacement surgery . Only patient older 50 year primary osteoarthritis include . The patient randomize 2 group . Intervention group receive injection 2ml Diprospan dilute 10 ml Bupivocaine . The control group receive injection 10ml Bupivocaine . All patient follow 6 week three functional rehabilitation pain score assess ( VAS pain score , Timed Up Go Score Functional Ambulatory Category Scale ) .</brief_summary>
	<brief_title>Evaluation Diprospan Injection Knee Rehabilitation Patients After TKR Contralateral Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone dipropionate , betamethasone sodium phosphate drug combination</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Age old 50 Bilateral primary knee osteoarthritis Undergoing knee arthroplasty Active infection Allergy medication compound Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee arthroplasty</keyword>
	<keyword>Steroid injection</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>